The 3 analysts offering 12-month price forecasts for AIM ImmunoTech Inc have a median target of 6.50, with a high estimate of 8.00 and a low estimate of 5.00. The median estimate represents a +196.80% increase from the last price of 2.19.
The current consensus among 3 polled investment analysts is to Buy stock in AIM ImmunoTech Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.08
Reporting Date Aug 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.